Clinical Trials in Ukraine: Untapped Potential & Proven Experience
Despite political unrest in a small section of the country, clinical trials are thriving in Europe’s second largest country. Large modern-treatment-naïve patient populations, expedient regulatory processes and a very low cost structure show why pharmaceutical companies have been conducting trials there for over 20 years.
Ukraine, the eighth largest European country by population, was often overlooked as a clinical trial site even before the political unrest and military actions that started in 2014. However, it remains an attractive location for those multinational companies astute enough to recognize its potential. The recent political unrest, which has been geographically confined, has closed off only about 7% of the country’s more than 575 clinical trial sites to multi-national companies (MNCs) for research studies.
Click the image to download the full whitepaper